Steven D. Davis

Steven D. Davis

Attorney Profile

Top Rated Products Liability Attorney in Edwardsville, IL

TorHoerman Law LLC
 | 210 S. Main Street, Edwardsville, IL 62025
Phone: 618-223-5657
Fax: 618-656-4401
Selected To Rising Stars: 2012 - 2018
Licensed Since: 2003
Practice Areas:
  • Personal Injury - Products: Plaintiff (40%),
  • Personal Injury - General: Plaintiff (30%),
  • Class Action/Mass Torts: Plaintiff (30%)
Attorney Profile

In his work at TorHoerman Law, Steven Davis fights for the rights of victims harmed by pharmaceutical, medical device, and chemical corporations when they put consumer safety behind their own profit goals.

Steven represents people injured by the wrongful acts of pharmaceutical companies in the development and marketing of dangerous drugs and medical devices. He currently represents individuals suffering serious injuries caused by the use of prescription medications such as Xarelto, Invokana, Zoloft, and fluoroquinolones, and represents hundreds of women injured by defective transvaginal mesh products.  His prior experience includes representing clients injured after use of hormone replacement therapy medications, prescription painkillers, SSRIs, and Pradaxa, including a role as co-liaison counsel for plaintiffs in the Pradaxa MDL, and he has represented many individuals injured by faulty heart devices.

TorHoerman Law LLC is a leader in the fight for justice against corporate greed. We fight for people injured by pharmaceutical drugs, toxic chemicals, and medical devices. Our knowledge of this complex legal arena is unsurpassed. TorHoerman Law LLC is proud of its results, but also of the exceptional personal attention given to each client.

About Steven Davis

Admitted: 2003, Illinois

Professional Webpage:


  • Magna Cum Laude - Southern Illinois University - Carbondale

Bar/Professional Activity:

  • Court Appointed Guardian ad litem in Madison County, IL
  • Co-Liason Counsel for MDL 2385 - Pradaxa (Dabigatran Etexilate) Products Liability Litigation
  • American Bar Association
  • Admitted to Missouri Bar
  • Cook County Bar Association
  • American Association for Justice
  • Admitted to California Bar
  • Madison County Bar Association
  • Illinois Trial Lawyers Association
  • Admitted to Illinois Bar

Pro bono/Community Service:

  • Through the THL Employee Charitable Foundation, we are able to pool our resources and make a difference in our community to those charities and initiatives that are important to the TorHoerman Law family.

Scholarly Lectures/Writings:

  • Since the first Case Management Order, setting the initial policies and protocols for the litigation, was entered in October, Zoloft litigation under the honorable Cynthia M. Rufe in the Eastern District of Pennsylvania has continued to move forward., Zoloft Litigation Continues to Move Forward, 2013
  • Everything Revolves Around Food: A Day in the Life of Someone with an Eating Disorder, Author, Everything Revolves Around Food: A Day in the Life of Someone with an Eating Disorder, Living Safer Magazine
  • Introduction to the Southern District of Illinois: How and When to File Your Pradaxa Case and an Update on Discovery, Speaker, Introduction to the Southern District of Illinois: How and When to File Your Pradaxa Case and an Update on Discovery, Harris Martin Pradaxa Litigation Conference
  • Speaker, Seminar on Handling the Pradaxa Claim: Damages, American Association for Justice, 2012
  • Summary of the differences between Pradaxa and Warfarin., Pradaxa v. Warfarin: The Rest of the Story, 2013
  • The FDA reports that bleeding rates do not appear to be higher with Pradaxa therapy than with warfarin therapy. The FDA reports that these findings are consistent with the RE-LY trial, which was a large clinical trial that served as the basis for the approval of Pradaxa., FDA Safety Announcement for Pradaxa Ignores Lack of Reversal Agent, 2012
  • Atrial fibrillation affects more than five million people in the U.S. It is a dangerous condition – a type of cardiac arrhythmia that greatly increases the risk of stroke., Pradaxa, Warfarin May See Increased Competition in Thinner Market, 2012
  • Boehringer Ingelheim has announced that it will publish additional data on its controversial and relatively new anticoagulant Pradaxa., New Pradaxa Data?, 2012
  • The FDA is now warning that the anticoagulant dabigatran (also known by its brand name Pradaxa) should not be prescribed to prevent stroke or thromboembolic events in patients with mechanical (also known as mechanical prosthetic) heart valves, FDA Warns Clinicians Against Prescribing Pradaxa to Patients with Heart Valves, 2012

Educational Background:

  • Southern Illinois University School of Law, J.D., 2003
  • Southern Illinois University - Carbondale IL, BS - Honors, Magna Cum Laude, 2000
Show More
Office Location for Steven D. Davis

210 S. Main Street
Edwardsville, IL 62025

Steven D. Davis:

Last Updated: 6/26/2019

Page Generated: 0.18551993370056 sec